| 摘要 |
The present invention relates to novel compounds, ester pro-drugs of [3-(1-(1 H -imidazol-4-yl)ethyl)-2-methylphenyl] methanol, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals in the treatment of conditions mediated by adrenergic receptors. |
